Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for upper airway obstruction during non-intubated intravenous general anesthesia
ChiCTR2300068540Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in upper airway obstruction (UAO) and hypopnea (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Rate of upper airway obstruction. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
upper airway obstruction (UAO)hypopnea
Beyond the preview
Go deeper on ChiCTR2300068540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068540.